High levels of serum cholesterol increase the risk of developing vessel co‐opting tumors in colorectal cancer liver metastases
The FEBS Journal · 2026
DOI: 10.1111/febs.70348 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2026. Verfasst von Amatzia Gantz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department Anatomy and Cell Biology, McGill University, Quebec, Canada. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, Cholesterol. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cholesterol availability has been implicated in cancer progression. Here, we demonstrate the connection between blood cholesterol concentration, the development of distinct histopathological growth patterns (HGPs) in colorectal cancer liver metastases (CRCLM), and new avenues of treatment for patients. Our study reveals that serum cholesterol levels correlate with the different HGPs, and patients on statins had desmoplastic HGPs and improved overall survival. We also demonstrate, in an in vivo mouse model, that inhibition of key modulators of cholesterol metabolism, using antiproprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, attenuated the development of CRCLM tumors, as well as the formation of vessel co‐opting lesions. Our findings underscore the importance of cholesterol in CRCLM and the potential clinical application of evolocumab to mitigate the growth of these histological types of tumors in CRCLM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department Anatomy and Cell Biology, McGill University, Quebec, Canada.
- Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, Canada.
- Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal, Canada.
ORCID-Profile: Amatzia Gantz, Audrey Kapelanski-Lamoureux, Miran Rada, Lucyna Krzywon, Migmar Tsamchoe, Anastasia Tsatoumas, Stephanie K Petrillo, Nabil G Seidah, Anthoula Lazaris, Peter Metrakos
Zitieren
APA
Gantz, A., Kapelanski-Lamoureux, A., Rada, M., Krzywon, L., Tsamchoe, M., Tsatoumas, A., Petrillo, S. K., Seidah, N. G., Lazaris, A., & Metrakos, P. (2026). High levels of serum cholesterol increase the risk of developing vessel co‐opting tumors in colorectal cancer liver metastases. The FEBS Journal. https://doi.org/10.1111/febs.70348
Vancouver
Gantz A, Kapelanski-Lamoureux A, Rada M, Krzywon L, Tsamchoe M, Tsatoumas A, et al. High levels of serum cholesterol increase the risk of developing vessel co‐opting tumors in colorectal cancer liver metastases. The FEBS Journal. 2026. doi:10.1111/febs.70348
BibTeX
@article{Gantz2026,
author = {Gantz, Amatzia and Kapelanski-Lamoureux, Audrey and Rada, Miran and Krzywon, Lucyna and Tsamchoe, Migmar and Tsatoumas, Anastasia and Petrillo, Stephanie K and Seidah, Nabil G and Lazaris, Anthoula and Metrakos, Peter},
title = {High levels of serum cholesterol increase the risk of developing vessel co‐opting tumors in colorectal cancer liver metastases},
journal = {The FEBS Journal},
year = {2026},
doi = {10.1111/febs.70348}
}
EUVIMED